{
    "clinical_study": {
        "@rank": "28417", 
        "arm_group": [
            {
                "arm_group_label": "Exercise", 
                "arm_group_type": "Experimental", 
                "description": "Aerobic Exercise, 3 times peer week, A dose of 16.5 kcal/kg weight peer week."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention"
            }
        ], 
        "brief_summary": {
            "textblock": "The study aimed to evaluate the use of exercise as a complementary strategy to treat severe\n      major depression in inpatients.\n\n      Hypothesis: Exercise can be used as a safe and efficacious complimentary strategy in severe\n      depressed inpatients."
        }, 
        "brief_title": "Exercise and Severe Depression: Clinical and Biological Analysis", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "condition": "Depression", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of Major Depressive Disorder according to M.I.N.I (DSM-IV) criteria\n             American Psychiatry Association(1994)\n\n          -  score of 25 or more on Hamilton-17\n\n          -  not being involved in other physical activity programs during the hospitalization\n\n          -  aged between 18 and 60 years\n\n          -  being able to read, understand, and provide written informed consent\n\n        Exclusion Criteria:\n\n          -  have three or more cardiovascular risk factors according to Physical Activity\n             Readiness Questionnaire (PAR-Q)\n\n          -  are unable to exercise due other clinical condition\n\n          -  have diagnosis of Schizophrenia, Bipolar disorder or current use of alcohol or other\n             drugs according to M.I.N.I DSM-IV criteria American Psychiatry Association(1994)\n\n          -  if they are taking beta-blocking medications"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01899716", 
            "org_study_id": "07-438"
        }, 
        "intervention": {
            "arm_group_label": "Exercise", 
            "intervention_name": "Exercise", 
            "intervention_type": "Other", 
            "other_name": [
                "Exercise", 
                "Aerobic Exercise"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Severe Depression", 
            "Quality of life", 
            "Exercise", 
            "BDNF", 
            "TBARS"
        ], 
        "lastchanged_date": "December 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Porto Alegre", 
                    "country": "Brazil", 
                    "state": "Rio Grande do Sul", 
                    "zip": "90035-903"
                }, 
                "name": "Hospital de Clincas de Porto Alegre"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Exercise and Severe Depression: Clinical and Biological Analysis", 
        "overall_official": [
            {
                "affiliation": "HCPA", 
                "last_name": "Felipe B Schuch, MSc", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HCPA", 
                "last_name": "Marcelo PA Fleck, PhD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Hamilton 17 for depression", 
            "measure": "Depressive symptoms", 
            "safety_issue": "No", 
            "time_frame": "2 weeks of hospitalization (14 days)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01899716"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "21616540", 
                "citation": "Schuch FB, Vasconcelos-Moreno MP, Borowsky C, Fleck MP. Exercise and severe depression: preliminary results of an add-on study. J Affect Disord. 2011 Oct;133(3):615-8. doi: 10.1016/j.jad.2011.04.030. Epub 2011 May 25."
            }, 
            {
                "PMID": "23565097", 
                "citation": "Schuch FB, de Almeida Fleck MP. Is Exercise an Efficacious Treatment for Depression? A Comment upon Recent Negative Findings. Front Psychiatry. 2013 Apr 2;4:20. doi: 10.3389/fpsyt.2013.00020. eCollection 2013."
            }
        ], 
        "secondary_outcome": [
            {
                "description": "WHOQOL-BREF", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "Baseline, after 2 weeks of hospitalization and at discharge (participants will be followed for the duration of hospital stay, an expected average of 3 weeks)"
            }, 
            {
                "measure": "Brain-Derived Neurotrophic Factor(BDNF)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, after 2 weeks of hospitalization and at discharge  (participants will be followed for the duration of hospital stay, an expected average of 3 weeks)"
            }, 
            {
                "measure": "Thiobarbituric acid reactive substances(TBARS)", 
                "safety_issue": "No", 
                "time_frame": "Baseline, after 2 weeks of hospitalization and at discharge (participants will be followed for the duration of hospital stay, an expected average of 3 weeks)"
            }, 
            {
                "description": "Hamilton Scores at discharge", 
                "measure": "Depressive symptoms at discharge  (participants will be followed for the duration of hospital stay, an expected average of 3 weeks)", 
                "safety_issue": "No", 
                "time_frame": "Discharge"
            }
        ], 
        "source": "Hospital de Clinicas de Porto Alegre", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hospital de Clinicas de Porto Alegre", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2008", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}